Home
About
Services
Partners
Client Portfolio
News
Contact
Coty appoints Chairman Peter Harf as CEO
June 1, 2020
Factbox: What’s new with the Fed’s 2020 bank stress tests?
June 1, 2020
0
Gilead trades that made millions on COVID-19 drug news raise eyebrows
Published by
Muller&Green
at
June 1, 2020
Categories
RSS
Tags
Well-timed trades in Gilead Sciences Inc’s options ahead of good news on the biopharmaceutical company’s COVID-19 drug treatment may draw regulatory scrutiny, experts said.
Powered by
WPeMatico
Muller&Green
Related posts
May 21, 2025
Higher Mortgage Rates? Steeper Inflation? What the U.S. Credit Downgrade Could Mean
Read more
May 20, 2025
How Trump’s Tariff Unpredictability Hurts Businesses and Consumers—and Could Help China
Read more
May 15, 2025
Walmart Warns It May Have to Raise Prices Starting This Month as Tariffs Are ‘Still Too High’
Read more